Xarelto Lawsuit Cases Consolidated By JPML Due To Similar Allegations Regarding The Drug
June 13, 2016 – – TheProductLawyers.com reports on the numbers of Xarelto lawsuits that have been consolidated together because of the uniformity of the allegations being made about the drug’s dangerous side effects. All plaintiffs are claiming that Xarelto may place patients using the drug at a much higher risk for dangerous and life-threatening instances of uncontrollable bleeding, as well as other adverse impacts. The consolidated cases also share the same defendants, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer AG, which manufacture the drug both overseas and in the United States.
There are currently two groups of consolidated cases. The first is a mass tort program in Philadelphia, PA that was completed under the direction of the Court of Common Pleas. There are 550 cases in this tort program, and it has been reported that since the cases are still in the pretrial and discovery phases, there may be a possibility of more lawsuits being filed, thus increasing the current number.
The second group of cases number over 2,800 and were consolidated into a Multidistrict Litigation (MDL) with a decree made by the U.S. Judicial Panel for Multidistrict Litigation (JPML) and has been assigned number 2592. The cases are being overseen and administered in a federal court in the Eastern District of Louisiana. Plaintiffs in all of the cases in the multidistrict litigation (MDL) concur that the manufacturers of Xarelto were negligent and reckless in releasing Xarelto onto the market without fully disclosing the nature of the potentially dangerous risks associated with the drug.
Xarelto has also been the recipient of two black box warnings by the U.S. Food and Drug Administration (FDA). A black box warning is the most severe warning that can be issued by the FDA and can frequently be a precursor to a drug being pulled from the market.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.
###
Contact TheProductLawyers.com:
Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023
ReleaseID: 60010643